Impact of Mepolizumab on Airway Remodeling and Inflammation in Severe Eosinophilic Asthma.

Saved in:
Bibliographic Details
Title: Impact of Mepolizumab on Airway Remodeling and Inflammation in Severe Eosinophilic Asthma.
Authors: Taillé C; Pneumology, Allergology and Transplantation Department, AP-HP, Hôpital Bichat, Paris, France; Inserm, Unit 1149, Université Paris Cité, Paris, France; Clinical Research Initiative in Severe Asthma: A Lever for Innovation & Science, Toulouse, France. Electronic address: camille.taille@aphp.fr., Hamidi F; Inserm, Unit 1149, Université Paris Cité, Paris, France., Heddebaut N; Inserm, Unit 1149, Université Paris Cité, Paris, France., Poté N; Department of Pathology, AP-HP, Hôpital Bichat, Paris, France., Le Guen P; Pneumology, Allergology and Transplantation Department, AP-HP, Hôpital Bichat, Paris, France., Le Brun M; Pneumology, Allergology and Transplantation Department, AP-HP, Hôpital Bichat, Paris, France., Roy C; Department of Statistics and Clinical Research, AP-HP, Hôpital Bichat, Paris, France., Dupont A; Department of Statistics and Clinical Research, AP-HP, Hôpital Bichat, Paris, France., Létuvé S; Inserm, Unit 1149, Université Paris Cité, Paris, France.
Source: Chest [Chest] 2026 Apr; Vol. 169 (4), pp. 890-901. Date of Electronic Publication: 2025 Dec 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1931-3543
DOI:10.1016/j.chest.2025.10.047